Supplementary Table S4 from ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair

2026 Open access

Read full text

Authors: Mengjun Sui, Qing Cai, Zhiwei Sun, Jinjin Li, Yiyang Zhang, Mengdan Li, Penggao Dai, Gang Li

DOI: 10.1158/1541-7786.30986393

Cited by: 0

Abstract

Supplementary Table S4. The primers were used in this article.

PARP inhibition in cancer therapy Sirtuins and Resveratrol in Medicine Cancer Lipids and Metabolism